Clinical trials
Phase 3 Thrombotic Microangiopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 3 |
| Novartis Pharmaceuticals | 3 |
| AKARI Therapeutics | 1 |
| Brigham and Women's Hospital | 1 |
| Omeros Corporation | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| University Hospital, Rouen | 1 |
| University Hospital, Tours | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombotic Microangiopathies | 12 |
| Atypical Hemolytic Uremic Syndrome | 5 |
| Acute Kidney Injury | 2 |
| COVID-19 | 1 |
| Glomerulonephritis, Membranoproliferative | 1 |
| Hematologic Diseases | 1 |
| Hemolytic-Uremic Syndrome | 1 |
| Kidney Diseases | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.